ClinConnect ClinConnect Logo
Search / Trial NCT03063216

Shanghai Pediatric Cataract Study

Launched by EVIDENCE BASED CATARACT STUDY GROUP · Feb 21, 2017

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The Shanghai Pediatric Cataract Study is looking into how well children with cataracts see after they have surgery. This study includes children with cataracts that are present at birth (congenital cataracts) and those caused by injury (traumatic cataracts). Researchers want to understand not only the outcomes of the surgery but also the genetic and environmental factors that might lead to cataracts in children.

To participate in this study, children must have a clinical diagnosis of pediatric cataract and be able to cooperate during eye exams. However, children with mental illnesses or disabilities are not eligible to join. Those who take part can expect regular eye examinations and follow-ups to track their visual progress over time. The study is currently recruiting participants, so it’s a good opportunity for families affected by pediatric cataracts to contribute to important research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Clinical diagnosis of pediatric cataract
  • Must be able to cooperate with the ophthalmic examination
  • Exclusion Criteria:
  • Clinical diagnosis of mental illness
  • Mentally disabled

About Evidence Based Cataract Study Group

The Evidence-Based Cataract Study Group is a dedicated clinical trial sponsor focused on advancing the understanding and treatment of cataracts through rigorous research. Committed to improving patient outcomes, the group conducts comprehensive studies that integrate evidence-based methodologies to evaluate the efficacy and safety of various cataract interventions. By fostering collaboration among leading ophthalmologists and researchers, the Evidence-Based Cataract Study Group aims to generate high-quality data that informs clinical practice and enhances the quality of care for individuals affected by cataracts.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Trial Officials

Yi Lu, M.D.

Study Chair

Eye and ENT Hospital of Fudan University

Xiangjia Zhu, M.D.

Study Director

Eye and ENT Hospital of Fudan University

Keke Zhang, M.D.

Principal Investigator

Eye and ENT Hospital of Fudan University

Wenwen He, M.D.

Principal Investigator

Eye and ENT Hospital of Fudan University

Yu Du, M.D.

Principal Investigator

Eye and ENT Hospital of Fudan University

Yinglei Zhang, M.D.

Principal Investigator

Eye and ENT Hospital of Fudan University

Ruiqi Chang, M.D.

Principal Investigator

Eye and ENT Hospital of Fudan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials